Abstract 7202: Comparative evaluation of 225Ac-PSMA-Trillium with other 225Ac-PSMA-SMOL assets in a preclinical prostate cancer xenograft model
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Bayer (Germany)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148739635
Cites:
Cited by:
Related to:
